News | Mammography | July 11, 2018

Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality

Breast imaging analytics software helps mobile mammography breast care team deliver personalized health with high-quality images

Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality

July 11, 2018 — Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is the first dedicated mobile mammography provider to adopt VolparaEnterprise software to help deliver high-quality, personalized breast cancer screening. Invision Diagnostics performs over 8,000 mammograms annually in three advanced mobile mammography coaches in Asheville, Charlotte, Raleigh, and other locations throughout the Southeast.

VolparaEnterprise software delivers key performance indicators for over 100 performance and quality metrics, including patient positioning and compression, which are widely viewed as the causes of most clinical image deficiencies, and associated with delayed detection of breast cancer. The software enables Invision Diagnostics' employees to perform rapid quality control checks that help optimize the productivity and efficiency of imaging resources. This in turn helps decrease costs through the reduction of retakes, increase employee effectiveness and enhance the patient experience. Additionally, VolparaEnterprise software has been designed to help facilities comply with the U.S. Food and Drug Administration (FDA's) new EQUIP (Enhancing Quality Using the Inspection Program) initiative.

"VolparaEnterprise software will ensure our patients receive the best mammogram possible by enabling us to monitor quality for every single image. It is also an invaluable tool used to advance technologists' positioning skills and to support our quality improvement programs," said Mike Dyer, CEO, Invision Diagnostics.

VolparaDensity, one of the clinical applications within VolparaEnterprise, will provide Invision Diagnostics' radiologists with automated, objective volumetric breast density assessments and a breast density category which has been shown to correlate to the Breast Imaging-Reporting and Data System (BI-RADS) 4th and 5th editions.

Volpara Solutions will demonstrate VolparaEnterprise and its entire suite of volumetric breast imaging tools at the Association for Medical Imaging Management (AHRA) 2018 Annual Meeting and Exposition, July 22-25 in Orlando.

"As a radiologist, my ability to detect breast cancer is limited by the quality of the mammogram images that are presented. VolparaEnterprise gives us the ability to monitor the technical quality of every mammogram performed in our mobile coaches. This provides our patients and their physicians with the confidence that they will consistently receive a high-quality mammogram," said Kenneth Fox, M.D., chief medical officer, Invision Diagnostics. "Additionally, with objective breast density assessment, we can more accurately identify high-risk patients that may require adjuvant screening."

For more information: www.volparasolutions.com

Related Content

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...